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 21 
Abstract 22 
BACKGROUND. The oxy-functionalization of non-activated carbon bonds by the bacterial 23 
cytochrome P450 BM3 from Bacillus Megaterium, presents a promising field in biosynthesis 24 
and it has gained much interest in recent decades. Nevertheless, the need for the expensive 25 
cofactor NADPH, together with low operational stability of the enzyme have made the 26 
implementation of this biocatalyst unfeasible in most cases for industry.  27 
RESULTS. P450 BM3 and glucose dehydrogenase (GDH), as a cofactor regeneration enzyme, 28 
were successfully co-immobilized obtaining a bi-functional self-sufficient oxidative biocatalyst. 29 
Firstly, a broad screening on 13 different supports was carried out. Afterwards, five selected 30 
agaroses with three different functionalities (epoxy, amine and aldehyde) were studied and 31 
their immobilization processes optimized. Finally, P450 BM3 and GDH, were co-immobilized on 32 
those supports showing the best performance for P450 BM3 immobilization: Epoxy-agarose 33 
(Epoxy-agarose-UAB) presenting 83% and 20% retained activities respectively; AMINO-agarose 34 
presenting 28% and 25% and Lentikats® with which both enzymes retained 100% of the initial 35 
activity. Furthermore, the re-utilization of the self-sufficient immobilized derivatives was 36 
tested in 5 repeated cycles. 37 
CONCLUSIONS. P450 BM3 and GDH have been successfully immobilized on three supports and 38 
their re-usability has been tested in a model reaction. It represents a step-forward for future 39 
P450 BM3 industrial implementations. 40 
 41 
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 43 
 44 
Introduction 45 
Cytochromes P450 (CYPs) are versatile monooxygenases able to hydroxylate non-activated 46 
carbon bonds with the only requirement of molecular oxygen and an electron donor. CYPs are 47 
found as: (i) double domain proteins, presenting a heme-containing oxidative part and a FAD-48 
/FMN-containing reductase; as (ii) triple domain enzymes with a third Ferredoxin subunit and 49 
(iii) as fusion proteins with just one enzymatic unit [1].  These enzymes have been in the focus 50 
of research in recent decades due to interest in their application as catalysts for the efficient 51 
production of fine chemicals, polymers, active pharmaceutical ingredients or nutritional 52 
supplements. They display a broad substrate range as well as the capability to catalyse a 53 
variety of oxidations including epoxidations, hydroxylation of aromatics, N-oxidation, 54 
deamination, dehalogenation and others [2]. 55 
P450 BM3 (EC 1.14.14.1) from Bacillus megaterium was discovered in 1986 and excels among 56 
CYPs because it presents the highest turnover numbers (17000 min-1 for arachidonic acid) [3], 57 
[4]. In contrast with eukaryotic CYPs, P450 BM3 is a self-sufficient soluble protein that contains 58 
both oxidative and reductase domains in the same polypeptide chain. Its natural substrates are 59 
medium to long chain fatty acids, however, as with other CYPs, P450 BM3 is a promiscuous 60 
enzyme. It accepts fatty amides and alcohols, hydroxylated fatty acids and ω-oxo fatty acids. It 61 
also displays, not only hydroxylating activity, but olefin epoxidation, ring expansion, 62 
heteroatom oxidation and dealkylation, and dehydrogenation across C-O, C-N and C-C bonds, 63 
as well as carbon-carbon bond formation and cleavage [5]. 64 
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There are some limitations in the large-scale application of P450 BM3 such as, low operational 65 
stability, a dependence on the expensive NADPH electron donor and low retained activity in 66 
organic media [6]. Thus, there have been few cases where it has been attempt to be used 67 
industrially [7], [8]. In order to tackle these bottlenecks, protein engineering, cofactor recycling 68 
systems, surface modifications, reaction media engineering or immobilization are the main 69 
strategies usually followed in biocatalytic processes. 70 
Regarding the low operational stability, immobilization has proven to be an efficient 71 
methodology for a broad type of oxidoreductases, not only for improving their stability but 72 
also for enhancing process metrics by biocatalyst recycling [9], [10]. In addition, immobilization 73 
can confer operational advantages such as the possibility to operate in continuous mode, 74 
reduction of foam formation, increased stability in organic solvents or simplified product 75 
purification [11], [12]. Immobilization of P450 BM3 has been pursued by other authors. For 76 
example, Maurer et. al. tried to immobilize it on a variety of commercially available supports 77 
[13]. They succeeded using the positively charged resins DEAE and SuperQ; and a Sol-Gel, but 78 
only the last one was found suitable for bioconversions. Axarli et. al immobilized a triple 79 
mutant onto Epoxy-sepharose, achieving retained activities of 81% and improved stabilities at 80 
37°C [14]. Weber et. al. entrapped the heme-domain of the P450 BM3 into mesoporous 81 
molecular sieves (MCM-41 and SBA-15) and found a correlation between the activity observed 82 
from the derivative and pore diameter [15]. Furthermore, Zhao et. al.  immobilized a mutant 83 
on DEAE-650S, further entrapped into k-carrageenan together with catalase and zinc dust 84 
(Zn/Co(III)sep) which served as electron source. They could operate the reactor during 10 85 
batch cycles with continued conversions above 80% [16]. Other successful and more recent 86 
examples involved the fusion of the enzyme to linkers that enabled immobilization on solid 87 
surfaces [17]–[19]. From all the works present in the literature, few are the cases where P450 88 
BM3 has been successfully immobilized covalently for bioconversion purposes. Many of the 89 
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above works focused on bio-sensing, in which low amounts of enzyme are required, or on the 90 
electrochemical study of the enzyme [20], [21]. For large scale applications, the attachment of 91 
large quantities of the enzyme to solid matrices by covalent bonds is a robust method that 92 
often confers novel properties to the enzyme and it does not present leaching. 93 
With regard to electron donors, there have been attempts to substitute the expensive NADPH 94 
co-substrate for less costly products, e.g. NADH or H2O2 by protein engineering [22]–[24]. 95 
Strategies for regenerating the expensive NADPH has been also studied both in enzymatic and 96 
non-enzymatic manners [25]–[27]. The use of whole cell biocatalyst expressing P450 has also 97 
been considered as a suitable and much cheaper strategy by taking advantage of the cellular 98 
metabolism for NADPH regeneration [28], [29].  However, the use of whole cells entails several 99 
drawbacks such as secondary undesired reactions or low reaction rates due to the substrate or 100 
product mass transfer limitation.  Among the different strategies for cofactor regeneration, the 101 
utilization of secondary enzymes that make use of sacrificial substrates is one of the most 102 
attractive systems. The use of enzymatic NADPH regeneration systems in P450-catalyzed 103 
reactions has been reported by other authors. Different enzymes such as glucose 104 
dehydrogenase, formate dehydrogenase or phosphite dehydrogenase proved to be efficient 105 
and suitable biocatalysts for this purpose [13], [30], [31], [32].  106 
In this work, a bi-functional self-sufficient oxidative biocatalyst is obtained by the successful 107 
co-immobilization of P450 BM3 and a GDH from Thermoplasma acidophilum as cofactor-108 
regenerating enzyme. Firstly, P450 immobilization was analysed prior to the selection of the 109 
best co-immobilization strategy since P450 is a less robust enzyme compared to GDH. Thus, 110 
deeper understanding of P450 BM3 immobilization by two different enzyme-support 111 
interactions (adsorption or covalent attachment) is presented.  In this sense, different supports 112 
presenting a broad range of features were tested to get insight in the optimal immobilization 113 
procedure that should be followed. Finally, co-immobilization of P450 BM3 and GDH was 114 
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performed by applying the best methodologies resulting for the P450 BM3. The encapsulation 115 
in polyvinyl alcohol particles (Lentikats®) was also studied for the confinement of both P450 116 
BM3 and GDH as an alternative to adsorption and covalent attachment strategies.   117 
The resulting-self-sufficient biocatalysts were tested in terms of operational stability in the 118 
hydroxylation of sodium laureate as a model reaction for proof-of-concept. 119 
 120 
Experimental 121 
Materials and supports 122 
Nicotinamide adenine dinucleotide phosphate sodium salts in its oxidized and reduced form 123 
(NADP+ disodium salt and NADPH tetrasodium salt) was purchased from BONTAC 124 
Bioengineering (Shenzhen, Guandong, China). All the other reagents were purchased from 125 
Sigma Aldrich® (St. Louis, MO, USA) and were of analytical grade if not stated elsewhere.  126 
The supports used in the screening section were donated by Purolite® Life Sciences (Bala 127 
Cynwyd, PA, USA) and their features are summarized in Table 2.  128 
The Epoxy-agarose-SIGMA was purchased from Sigma-Aldrich®. According to the supplier’s 129 
specifications it presented spherical shape, it had an activation degree of ≥ 20µmol/mL and 12 130 
atoms spacer.  131 
Non-functionalized agarose (spherical beads Ø 50-150µm) purchased from Agarose Bead 132 
Technologies® (ABT®, Madrid, Spain) was used for obtaining Epoxy-agarose-UAB by support 133 
functionalization carried out as described by Axarli et. al. [14]. The quantification of the epoxy 134 
groups present on the supports was done following the method described by Gupta [33].  135 
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Amino functionalized agarose (AMINO-agarose) presenting amino ethyl groups and aldehyde 136 
functionalized agarose (GLYOXYL-agarose) with an extent of labelling of 40-60µmol/mL both 137 
were also purchased from ABT®. All this information was always according to the supplier’s 138 
specifications.  139 
Lentikats® polymer was purchased from GeniaLab® (Braunschweig, Germany) and its 140 
composition consists on a mixture of polyvinyl alcohol (10%), polyethylene glycol (6%) and 141 
demineralized water (84%).  142 
Recombinant expression of P450 BM3 and Glucose dehydrogenase in E. coli 143 
P450 BM3 (CYP102A1 from Bacillus megaterium BM3) was recombinantly produced in 144 
Escherichia coli in a 20 L scale batch fermentation employing an E. coli K12 derivative and a 145 
pBAD/myc-HisC based expression vector. Glucose Dehydrogenase (GDH) from Thermoplasma 146 
acidophilum (GDH-Tac) was co-expressed from the same vector in a poly-cistronic 147 
arrangement of the GDH gene downstream of the P450 BM3 gene.  A 500 ml pre-culture were 148 
used to inoculate 20 kg main culture medium with 100 µg/ml neomycin. The pre-culture was 149 
prepared in standard Luria-Bertani (LB) medium supplemented with 100 µg/ml neomycin. The 150 
fermentation was performed using terrific broth (TB) medium with glycerol. 2.5 h after 151 
inoculation of the fermenter as inducer, pre-sterilized L-arabinose was added to the fermenter 152 
to final concentration 0.02 % (w/v). 24 hours after inoculation of the fermenter, the cell 153 
material was harvested by centrifugation. Cell free extract was prepared by adding 2 weight 154 
equivalents of 100 mM potassium phosphate (KPi) buffer (pH 7.0) to 1 weight equivalent of E. 155 
coli wet cells and sonication of this cell suspension with an ultrasound probe for 20 min with 156 
cooling on ice and centrifugation to remove the cell-debris. 157 
Total protein and enzyme content 158 
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The cell lysate was pre-clarified by centrifugation (3220g for 15min.) and analysed accounting 159 
for total protein content by means of Bradford Protein Assay Kit (Thermo Fisher Scientific, 160 
Waltham, USA) using bovine serum albumin as standard [34]. 161 
Enzyme content was assessed using the sodium dodecyl sulphate polyacrylamide gel 162 
electrophoresis (SDS-PAGE) (NuPage 12%, Invitrogen, USA) run in a Mini-PROTEAN II apparatus 163 
(BioRad, USA) following the protocol of Laemmli et. al. [35]. Low range protein markers were 164 
used for molecular weight determination. Gels were stained using Comassie G250 colloidal 165 
stain solution [34% (v/v) ethanol, 2% (v/v) H3PO4, 17% (w/v) NH4SO4 and 0.066% Comassie 166 
G250] and the Image LABTM software (BioRad, USA) was used for image processing. 167 
Active P450 BM3 content determination 168 
P450 BM3 active form concentration was determined using the CO-differential spectra analysis 169 
described by Omura and Sato, using ε = 91 mM-1 cm-1 [36], [37]. 170 
P450 BM3 activity measurement 171 
The activity of the P450 BM3 was measured spectrophotometrically (λ=340nm) following the 172 
consumption of NADPH (ε= 6.22 mM-1 cm-1, 200µM), using sodium dodecanoate (sodium 173 
laurate) as substrate (1,3 mM dissolved in sodium phosphate buffer 50mM pH=7,5) and the 174 
correspondent amount of sample [1/20 of the total volume (VT)]. The basal consumption of 175 
NADPH by unspecific enzymes present in the lysate was determined by this same test but 176 
avoiding the addition of the substrate and adding buffer instead. This consumption rate is 177 
subtracted from the measurement with sodium dodecanoate. One unit of activity (UA) is 178 
defined as the enzyme required to convert 1µmol of NADPH per minute at those given 179 
conditions (30°C and pH = 7.5). The absorbance was recorded using a spectrophotometer Cary 180 
50 Bio UV-visible (Palo Alto, USA). The equipment allows temperature control and stirring. 181 
Plastic micro cuvettes BRAND® UV (Sigma Aldrich®) were used for soluble enzyme 182 
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characterization and 3.5mL quartz cuvettes HELLMA® 100-QS (Hellma Analytics, Müllheim, 183 
Germany) with magnetic stirring, were used for the immobilized derivatives (suspension). In 184 
the first case a total volume of 500µL was reached while in the second it was 2mL. 185 
Glucose dehydrogenase activity measurement 186 
GDH activity is measured spectrophotometrically (λ=340nm) following the formation of 187 
NADPH. Certain amount of sample (1/20 of the VT) was added to a solution containing D-188 
Glucose (200mM dissolved in sodium phosphate buffer 100mM pH=8) and NADP+ (400µM). 189 
The same procedure explained above was applied for measuring the non-GDH formation of 190 
NADPH and the same consideration is taken to obtain the UAs. The absorbance was also 191 
recorded using the aforementioned equipment and conditions. 192 
Immobilization metrics 193 
In every immobilization, a characterization was pursued in order to obtain the retained activity 194 
(equation 1) and immobilization yield (equation 2).  Supernatant and suspension activities 195 
were analysed over time until a steady state was reached and in all cases the activity of a blank 196 
(no support) was also monitored to ensure that the enzyme activity was not affected by 197 
protocol’s conditions. A 10% w/v relation between the support and the total volume was 198 
always stablished and small amounts of enzyme were loaded (4-5UA of P450 BM3/g of support 199 
and 5-6UA of GDH/g of support) so that diffusional limitations were minimized. 200 
𝑅𝑒𝑡𝑎𝑖𝑛𝑒𝑑 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 (%) =
𝑆𝑢𝑠𝑝𝑒𝑛𝑠𝑖𝑜𝑛 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 (
𝑈𝐴
𝑔
)−𝑆𝑢𝑝𝑒𝑟𝑛𝑎𝑡𝑎𝑛𝑡 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 (
𝑈𝐴
𝑔
)
𝐼𝑛𝑖𝑡𝑖𝑎𝑙 𝑜𝑓𝑓𝑒𝑟𝑒𝑑 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 (
𝑈𝐴
𝑔
)
 𝑥 100   (Equation 1) 201 
𝐼𝑚𝑚𝑜𝑏𝑖𝑙𝑖𝑧𝑎𝑡𝑖𝑜𝑛 𝑦𝑖𝑒𝑙𝑑 (%) = (1 −  
𝑆𝑢𝑝𝑒𝑟𝑛𝑎𝑡𝑎𝑛𝑡 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 (
𝑈𝐴
𝑔
)
𝐼𝑛𝑖𝑡𝑖𝑎𝑙 𝑜𝑓𝑓𝑒𝑟𝑒𝑑 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 (
𝑈𝐴
𝑔
)
)  𝑥 100   (Equation 2) 202 
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For the assessment of the loading capacity the supports were saturated with enzyme and the 203 
activity was calculated taking into account that diffusional limitations do not allow the actual 204 
visualization of the activity in the support (equation 3). 205 
𝐿𝑜𝑎𝑑𝑖𝑛𝑔 𝑐𝑎𝑝𝑎𝑐𝑖𝑡𝑦 (
𝑈𝐴
𝑔
) = (𝑂𝑓𝑓𝑒𝑟𝑒𝑑 𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 (
𝑈𝐴
𝑔
) −206 
 𝑆𝑢𝑝𝑒𝑟𝑛𝑎𝑡𝑎𝑛𝑡 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 (
𝑈𝐴
𝑔
))  𝑥 
𝑅𝑒𝑡𝑎𝑖𝑛𝑒𝑑 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 (%)
𝐼𝑚𝑚𝑜𝑏𝑖𝑙𝑖𝑧𝑎𝑡𝑖𝑜𝑛 𝑦𝑖𝑒𝑙𝑑 (%)
   (Equation 3) 207 
Moreover, the amount of protein per gram of support was also calculated, analysing the initial 208 
protein content and subtracting from it, the concentration still remaining in the supernatant at 209 
the end of the process. In all cases protein concentration was determined by means of 210 
Bradford Protein Assay Kit, as already described. 211 
Immobilization of P450 BM3 onto Purolite® resins 212 
From Purolite®, a set of commercially available resins presenting a variety of matrices, pore 213 
sizes, linker lengths, and functional groups (Table 2) were tested for the immobilization of 214 
P450 BM3. The conditions in which immobilizations were carried out in each case were those 215 
specified by the supplier’s protocols. In all cases, the relation of 10% w/v between support and 216 
total volume was maintained. The immobilizations were done at 25°C and mild agitation. The 217 
incubation times ranged from 0.5 to 5 hours depending on the speed at which the enzymes 218 
were attached. The epoxy containing methacrylates (ECR8204F, ECR8215F and ECR8285) were 219 
used in 50mM sodium phosphate buffer pH 8 containing 0.5M NaCl. The amino functionalized 220 
resins (ECR8309F, ECR8315F, ECR8409F and ECR8415F) were mixed with the enzyme in 50mM 221 
sodium phosphate buffer pH 6. The supports made of a mixture of styrene and methacrylate 222 
(ECR1061M and ECR1030M) were utilized in 50mM sodium phosphate buffer pH 7.5; finally, 223 
immobilizations using the epoxy agaroses (Praesto 45, 65 and 90) were performed in 1M 224 
potassium phosphate buffer pH 8.  225 
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Immobilization of P450 BM3 onto Epoxy-agarose-SIGMA and Epoxy-agarose-UAB supports 226 
For the other epoxy-agaroses (Epoxy-agarose-SIGMA and Epoxy-agarose-UAB), the enzyme 227 
was dissolved in 1M (pH 8) potassium phosphate buffer, mixed with the resin (10% w/v) and 228 
left at 25°C with mild agitation. The Epoxy-agarose-UAB was incubated for 4 hours and Epoxy-229 
agarose-SIGMA was incubated for 0.5h. At the end of the process, in order to eliminate the 230 
unreacted epoxy groups, the samples were incubated with 0.2M β-mercaptoethanol for at 231 
least 2h at 25°C.  232 
Immobilization of P450 BM3 onto GLYOXYL-agarose support 233 
For the immobilization using GLYOXYL-agarose different pH’s were tested (6.5 – 8.5) using 234 
50mM sodium phosphate buffers. The immobilizations lasted 6 hours and were done at 25°C 235 
and mild agitation. For the reduction of the Schiff base, two different reducing agents were 236 
studied: sodium borohydride (1mg/mL) added at the end of the immobilization and sodium 237 
cyanoborohydride (0.05mg/mL for characterization and 0.4mg/mL for high loads of enzyme) 238 
added at the beginning of the immobilization. 239 
Immobilization of P450 BM3 onto AMINO-agarose support 240 
For AMINO-agarose 50mM sodium phosphate buffer (pH 6) was used to dissolve the enzyme 241 
and mix it with the support. Coming up next, the enzyme was left to ionically adsorb onto the 242 
support for 0.5h-1h. After that, N-(3-Dimethylaminopropyl)-N'-ethylcarbodiimide (EDC) was 243 
added and incubated for 30min. at different concentrations to activate the carboxylic groups 244 
and promote the covalent binding. The concentration of EDC was optimized in the 245 
characterization phase (1, 2, 3, 4, 5, 10, 15, 20mM) and also when using high loads of enzyme 246 
(3, 6, 12, 30, 60mM). Finally, 0.5M NaCl was introduced to desorb all the protein attached non-247 
covalently. The immobilization was carried out at 25°C and mild agitation. 248 
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Co-immobilization of P450 BM3 and GDH in AMINO-agarose and Epoxy-agarose-UAB  249 
The conditions in which immobilizations were carried out were exactly the same as previously 250 
described for P450 BM3 for AMINO-agarose and Epoxy-agarose-UAB. The activity of the GDH 251 
present in the lysate was also monitored in this stage together with the P450 BM3. Retained 252 
activities and immobilization yields were obtained for GDH and P450 BM3. 253 
Co-Immobilization of P450 and GDH into polyvinyl alcohol lenses (Lentikats®) 254 
Co-immobilization of GDH and P450 BM3 by entrapment was carried out using an organic 255 
polymer commercialized as Lentikats®. The solid mixture was heated up to 95°C until it turned 256 
into a transparent liquid. Then it was cooled down to 40°C and 8mL of the polymer were mixed 257 
with 2mL of a suspension containing the desired amount of biocatalyst. Afterwards the 258 
mixture was poured on a petri dish and the lenses were printed using the LentiPrinter®. The 259 
resulting plates were left to dry at 25°C for 1h until they lost 80% of its weight approximately. 260 
Once printed, the support adopted a lentil-like shape of 1-2mm diameter and 200-300µm wide 261 
where the proteins were entrapped inside. 262 
Re-usability of the biocatalyst for the hydroxylation of sodium laureate 263 
The utilization of the immobilized enzymes in repeated reaction cycles were studied following 264 
the consumption of sodium laurate. The reactor (VT=5mL) contained 1.53mM sodium laurate, 265 
0.2mM NADP+ and 12.5mM D-glucose. All dissolved in 50mM sodium phosphate buffer pH 7.5. 266 
The enzyme added was the minimum necessary to convert at least 90% of the initial substrate 267 
in 1hour. The reactors used were purchased from MultiSynTech (Witten, Germany) and 268 
consisted of 10mL plastic vessels with a porous plate at the bottom. It allowed the extraction 269 
of the whole reactor liquid content by filtering with this same porous plate without losing any 270 
fraction of the immobilized derivative. The reaction took place at 25°C and 1000 rpm using a 271 
Multi-Therm H5000-HC-E thermo-shaker (Benchmark Scientific Inc., Sayreville, NJ, USA). After 272 
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each cycle, the immobilized enzymes were washed twice with sodium phosphate buffer 50mM 273 
pH 7.5 then new reaction medium was added and substrate conversion was quantified. 274 
Experiments were carried out in duplicate. 275 
GC-FID analysis of sodium laurate 276 
Samples containing sodium laurate and its products were analysed using a 7890A gas 277 
chromatograph (Agilent Technologies, USA) equipped with a HP-INNOWAX 19095N-123 278 
column (30m, 0.53mm, 1µm, Agilent Technologies). Reaction samples were filtered (Ø 0.22µm) 279 
and 50µL of hexanoic acid (2.8mg/mL), that served as internal standard, were added to 300µL 280 
of sample. The column temperature started at 150 °C, increased to 240 °C at 24 °C/min. and it 281 
was held at final temperature for 11 minutes. The injector temperature was kept at 300 °C; for 282 
the flame ionization detector, the temperature was 320 °C. Helium was used as a carrier gas at 283 
a flow rate of 8 mL/min. All analyses were carried out in duplicate. 284 
 285 
Results and discussion 286 
Characterization of the E. coli lysate containing P450 BM3 and GDH 287 
As already mentioned, P450s are enzymes that require a cofactor to perform the redox 288 
reactions they catalyse. One of the strategies widely used for overcoming the disadvantages of 289 
co-factor dependency is the use of an enzyme-coupled reaction for the regeneration of the 290 
expensive NADPH. In this work, GDH (EC 1.1.1.47) from the archaea Thermoplasma 291 
acidophilum was used as NADPH-recycling enzyme using glucose as sacrificial substrate. This 292 
robust and stable tetrameric protein is reported to be an efficient enzyme for NADPH 293 
regeneration [31], [32], [38]. 294 
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In the present work, GDH was co-expressed with P450 BM3 in E. coli and both enzymes were 295 
present in the cell lysates utilized.  296 
The characterization of the lysate was performed regarding protein content, enzyme content 297 
(SDS-PAGE), activity and P450 BM3 active form concentration and the results are shown in 298 
Table 1. 299 
The P450 BM3 was expressed at a higher level than the GDH, however, under the conditions in 300 
which the activity tests were performed, GDH gave higher specific activity. Table 1, also shows 301 
the correlation between Units activity (UAs) and concentration (nmols) of active enzyme; for 302 
the P450 BM3 case, 2.85 UA/nmol.  303 
Screening of supports for the immobilization of P450 BM3 – Purolite® 304 
The main objective of the present work was to obtain a bi-functional self-sufficient oxidative 305 
biocatalyst by co-immobilization of P450 BM3 and GDH. To accomplish this, supports and 306 
immobilization conditions that were found to be most suitable for the P450 BM3 enzyme were 307 
prioritised, since cytochrome is the key enzyme performing the target reaction and it has been 308 
described as an unfavourable enzyme for immobilizing. GDH, on the contrary, has been 309 
described as a robust and more stable enzyme so difficulties in its immobilisation were not 310 
anticipated [38]. In fact, successful immobilization of GDH on different kinds of support has 311 
been reported by several authors [39].  The results obtained for P450 BM3 immobilization, the 312 
materials tested and its features are summarized in Table 2. The supports purchased in the 313 
screening kits encompass a range of different particle sizes (45µm to 710µm), matrices 314 
(methacrylate, styrene and agarose), functional groups (amino, epoxy and aldehyde), enzyme-315 
support interaction (covalent binding or hydrophobic adsorption) and linker lengths (2 to 18 316 
carbon atoms). All of these properties have been identified as critical for successful enzyme 317 
immobilization [12].   318 
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As shown in Table 2, the immobilization yields obtained were higher than 90% in all cases, 319 
except for the supports that interact with the enzyme by hydrophobic adsorption: ECR1061M 320 
and ECR1030M.   In both cases the immobilization yields only reached 21% and 33% 321 
respectively. On the other hand, no retained activities or very low values (<20%) were 322 
observed in all tested supports, except for Praesto 45, 65 and 90 (Entries X to X; all epoxy-323 
agarose supports). According to the titration performed, Praesto 45, 65 and 90 all contained an 324 
epoxide concentration of 9, 6 and 8µmol per gram of support respectively and resulted in 325 
retained activities of 60-68% after 4h incubation. The maximum loading capacities of these 326 
epoxy-agarose resins ranged from 18 to 20UA/g and 7 to 8mg protein/g of support. The 327 
immobilization profiles were very similar among the three supports and they did not show any 328 
significant correlation with the particle size or the initial epoxide concentration (Fig. 1A).   329 
Regarding the methacrylate and styrene matrices, even though different ionic strengths and 330 
pH values were assessed, none of the tested supports showed retained activities above 20%. 331 
P450 BM3 had adhered to the matrices in most cases, but did not remain active. Two 332 
methacrylate-based materials harbouring amino groups on six carbon chain linkers (ECR8409F 333 
and the ECR8415F) gave retained activities of 24% and 22% respectively when the enzyme was 334 
adsorbed onto the resins solely by ionic interactions, however once carbodiimide was added, 335 
to promote covalent bond formation, the activity was reduced to 6% and 18% respectively. 336 
Furthermore, following the supplier’s protocol, the four amino methacrylate based supports 337 
were further functionalized with glutaraldehyde prior to enzyme binding, but none resulted in 338 
successful immobilization either.  339 
It should be also mentioned that methacrylic matrices with the same functional groups than 340 
the epoxy-agarose support (ECR8204F, ECR8215F and ECR8285) did not lead to actively 341 
immobilized enzyme, as can be seen by the low retained activities obtained (0%, 2% and 3% 342 
respectively). These results could indicate that for P450 immobilization the hydrophilicity of 343 
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the matrix is a key factor. The higher hydrophobicity of the methacrylate/styrene matrices, 344 
together with the flexible nature of the enzyme and the presence of two active sites, are 345 
probably the causes behind the deactivation of the biocatalyst [40]. This hypothesis would be 346 
also in accordance with the low immobilization yields and retained activities obtained with the 347 
styrene matrices (ECR1061M and ECR1030M) where, because the immobilization mechanism 348 
is also based on hydrophobic adsorption to the highly hydrophobic nature of the matrix, both 349 
the immobilisation yield and retained activity are low. Other authors have also reported 350 
unsuccessful attempts to immobilize P450s by hydrophobic adsorption [13]. 351 
Taking into account the obtained results in the screening which showed a strong effect of the 352 
hydrophilicity of the matrix on P450 immobilization, agarose was chosen to perform further 353 
studies. 354 
Immobilization of P450 BM3 onto different functionalized agaroses 355 
In addition to the epoxy resins already tested (Praesto 45, 65 and 90), two other agarose 356 
matrices with free epoxy groups and different expoxide concentrations were studied: a 357 
commercial lyophilized epoxy-agarose resin from Sigma-Aldrich® (Epoxy-agarose-SIGMA) and 358 
an in-house functionalized agarose resin (Epoxy-agarose-UAB) prepared as shown in the 359 
experimental section. In addition an agarose based matrices containing aldehyde (GLYOXYL-360 
agarose) and primary amine (AMINO-agarose) functional groups were tested.  361 
The Epoxy-agarose-SIGMA resin, according to the titration performed, contained an epoxide 362 
concentration of 110µmol/g and gave an  immobilization yield of greater than 95% after 0.5h 363 
(Figure 1B). However, a rapid decrease in activity of the suspended biocatalyst was noted 364 
during the immobilization procedure, indicating a strong deactivation of the enzyme after 365 
immobilization. Thus, after just half an hour, low retained activities (25%) were observed from 366 
this support. These results could indicate that the utilization of an epoxy-agarose with high 367 
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epoxide concentration, such as the Epoxy-agarose-SIGMA, results in a progressive loss of 368 
activity over time due to the multipoint attachment of the enzyme to the support [41]. The 369 
explanation can be found in the reactivity of the epoxy groups which differs over time: firstly, 370 
reacting with the amines present on the surface of the enzyme and secondly reacting with the 371 
carboxyl and thiol groups and [42]. At the end, if the incubation time is long enough, the 372 
protein can be attached by too many points and lose its whole catalytic activity. This issue can 373 
be stopped adding a blocking agent that removes the unreacted epoxy groups once the 374 
protein is immobilized. In Figure 1B, β-mercaptoethanol (0.2M final concentration) was added 375 
after 0.5h and the suspension was incubated for 3.5h at 25°C. No significant loss of activity was 376 
observed during this period which validates the hypothesis of the multipoint attachment as 377 
the main reason for enzyme deactivation. However, due to its elevated cost (118€/g) and low 378 
retained activities, compared to the Praesto supports, the Epoxy-agarose-SIGMA was 379 
discarded from further studies.  380 
On the other hand, the Epoxy-agarose-UAB displayed an epoxide concentration of 30µmol/g 381 
and gave more than a 95% immobilization yield and 83% retained activity after 0.5h (Figure 382 
1C), with a maximum loading capacity of 30UA/g (7.5mg protein/g support). A decrease in 383 
retained activity can be also seen, reaching 50% after 4h of incubation probably due to the 384 
excessive number of covalent bindings. In this case, as well as for Praesto supports (Figure 1A), 385 
the agarose contains a lower epoxide concentration compared to Epoxy-agarose-SIGMA. 386 
Therefore, the activity loss due to the multipoint attachment is lower for the Epoxy-agarose-387 
UAB or even negligible for the Praesto compared to the Epoxy-agarose-SIGMA. Thus, when 388 
choosing the right support, a consensus should be found. Higher epoxide concentration may 389 
imply higher loading capacity as is seen when comparing Praesto (18 to 20 UAs/g) and Epoxy-390 
agarose-UAB (30UAs/g); however, at the same time, higher epoxide concentration entails 391 
higher deactivation of the enzyme over time as it is the case comparing all three epoxy-392 
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agaroses: Praesto (32-40% activity lost), Epoxy-agarose-SIGMA (75% activity lost) and Epoxy-393 
agarose-UAB (50% activity lost). In this sense, due to the loading capacity, the high retained 394 
activities reached and the low cost (2.5€/g), the Epoxy-agarose-UAB was considered the best 395 
candidate for the immobilization of P450 BM3 among epoxy-agaroses. This study represents a 396 
deeper insight into the work of Axarli et. al. [14] in the understanding of the immobilization of 397 
P450 BM3 on epoxy-agaroses and sets the bases for an optimal process.  398 
As mentioned before, other agarose-based supports with different functional groups were also 399 
tested such as GLYOXYL-agarose and AMINO-agarose. The GLYOXYL-agarose (aldehyde 400 
activated) immobilization must be pursued in alkali media [43], however, P450 BM3 is not 401 
stable above pH 8.5 (data not shown). After screening a range of immobilization pH’s (6.5 – 402 
8.5), 7.5 was the best performing one resulting in 50% retained activity after 6h incubation 403 
(data not shown). For the reduction of the Schiff base formed between the aldehyde of the 404 
resin and the amine of the enzyme, two reducing agents were tested: i) sodium borohydride 405 
(1mg/mL) which is added at the end of the incubation and ii) sodium cyanoborohydride 406 
(0.05mg/mL) which has slower kinetics and can be added at the beginning of the 407 
immobilization. Sodium borohydride resulted in a complete deactivation of the enzyme whilst 408 
the sodium cyanoborohydride strategy resulted in 36% of retained activity. Thus, sodium 409 
cyanoborohydride was selected as the most suitable reducing agent. Regarding the studies on 410 
maximum loading capacity, the values previously obtained in the characterization (36% 411 
retained activity) at low enzyme loadings were not extrapolated and a major inactivation 412 
occurred. This support has proved suitable for the immobilization of P450 BM3, nevertheless, 413 
since the covalent immobilization using high loading was not successful, it was discarded from 414 
further studies. 415 
Regarding AMINO-agarose, as for the other tested supports functionalized by amino groups 416 
(i.e. ECR8309F, ECR8315F, ECR8409F and ECR8415F) the immobilization is based on a three-417 
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stage process. In the first stage, the enzyme is adsorbed onto the support surface by ionic 418 
interaction of the amino groups of the support and the carboxyl groups of the enzyme, thus an 419 
ionic adsorption occurs. In the second stage, carbodiimide is added to the medium aiming to 420 
activate the carboxyl groups present on the enzyme making covalent bonding possible. 421 
Solutions with high ionic strength such as sodium chloride (0.5M) can be finally added to 422 
desorb all the protein attached non-covalently (third stage). Ionic adsorption on AMINO-423 
agarose was performed at pH 6 and gave a 58% retained activity (Figure 1D phase I). This value 424 
was 2.8-fold higher than the retained activities obtained during the ionic adsorption for the 425 
methacrylate based materials ECR8409F and ECR8415F harbouring the same functional group 426 
(21%), as previously discussed. The maximum loading capacity achieved was 112UA/g (50mg 427 
protein/mL) which represents the highest value among all the resins tested. Covalent binding 428 
of the amine and the carboxyl groups was carried out by adding EDC following ionic adsorption 429 
phase (Figure 1D phase II). Since carbodiimide can lead to enzyme deactivation, different 430 
concentrations and incubation times were studied to determine the optimal conditions for the 431 
covalent binding phase. These studies showed optimal values of 3mM EDC and 30min reaction 432 
time respectively. Following covalent attachment, the biocatalyst was incubated with 0.5M 433 
NaCl for 2h (Figure 1D, phase III) in order to increase the ionic strength of the media and 434 
release all the protein not adhered covalently. 28% of the initial activity offered was covalently 435 
bound to the agarose, which represents 30% less activity than the value obtained for the ionic 436 
adsorption phase (Figure 1D, phase I). On the other hand, compared to the methacrylate-437 
based supports, the retained activity was 4.7-fold and 1.6-fold higher than the obtained with 438 
ECR8409F and ECR8415F respectively.  Regarding the maximum load, 53UA/g was reached (47 439 
mg protein/mL), representing a 52% decrease in immobilized activity compare to the obtained 440 
by ionic adsorption, likely due to enzyme deactivation caused by the carbodiimide. When 441 
testing for the maximum loading capacity the concentration of EDC was further optimized 442 
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since more enzyme was added (Figure 2). It resulted in an optimal concentration between 6 443 
and 12mM. This second value was chosen due to the higher immobilization yield that it 444 
entailed. This support represents a step forward in comparison with the other tested agaroses 445 
and it is the first work reporting a successful covalent immobilization of P450 BM3 in an 446 
amino-based matrix. 447 
Co-immobilization of P450 BM3 and Glucose dehydrogenase 448 
As it has been already mentioned, for co-immobilization of both GDH and P450 BM3, it was 449 
considered to prioritize the supports and immobilization conditions that were found to be 450 
suitable for P450 BM3, i.e. Epoxy-agarose-UAB and AMINO-agarose.  451 
The immobilization of GDH using Epoxy-agarose-UAB resulted in poor affinity of the protein for 452 
the support with immobilization yields below 20%. However, of the enzyme that did adhere, a 453 
slight over-activation was observed compared to the same quantity of free enzyme. At the end 454 
of the incubation (4h), retained activity of 20% and a maximum loading capacity of 3UA/g were 455 
achieved. Since the conditions were exactly the same as reported above for P450 BM3, the 456 
activity for the cytochrome was comparable and resulted in 50% retained activity and 30UA/g 457 
(7.5mg protein/g support). 458 
With AMINO-agarose, GDH presented high affinity for the support and it also showed an over-459 
activation effect when adhered to the matrix. It had better tolerance to the presence of EDC 460 
compared with P450 BM3, with 10mM being the optimal concentration for this enzyme (57% 461 
retained activity) in the characterization phase. Coimmobilisation of both enzymes, initially 462 
using a low carbodiimide concentration of 3mM, resulted in a 25% retained activity for GDH 463 
and 28% for P450 BM3. Using a higher loading of EDC (12mM) resulted in a loading capacity of 464 
18 UA/g for GDH and 53 UA/g for P450 BM3. In summary, a self-sufficient oxidative biocatalyst 465 
was obtained. 466 
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Co-immobilization of P450 BM3 and GDH into polyvinyl alcohol particles - Entrapment 467 
Finally, as an alternative to immobilization by adsorption or by covalent attachment, an 468 
entrapment strategy was also investigated for co-immobilization. Both P450 BM3 and GDH 469 
were successfully embedded into Lentikats® (polyvinyl matrix) as described in the 470 
experimental section. The analysis undertaken, showed maximum retained activities of 100% 471 
for both P450 BM3 and GDH. 472 
In the sense of the loading capacity employed, the activity and concentration of protein in the 473 
polymer was 1.8UA/g of P450 BM3, 0.8UA/g of GDH and 1.1mg protein/g respectively. It was 474 
not further increased due to operational issues. The capacity is limited by an aggregation effect 475 
observed when charging high concentrations of lysate with which the lenses form a compact 476 
mass that cannot be used in our reactions. This entails a serious drawback when looking to 477 
industrial feasibility because the enzyme should be previously purified or the specific activity 478 
of the support would remain too low [28]. However, since the immobilization had been 479 
successful, albeit with low enzyme loading, and it is the first work that reports a successful 480 
entrapment of both P450 and GDH in Lentikats ®, it was decided to continue working with this 481 
immobilized derivative. 482 
Reusability of the biocatalyst using sodium laurate as substrate 483 
From all the supports tested, AMINO-agarose, Epoxy-agarose-UAB and Lentikats® were 484 
considered good candidates to be potential carriers in bio-catalysis applications. It is well-485 
known that uncoupling effects on P450s produce reactive oxygen species that inactivate the 486 
enzyme (uncoupling) [44]. This handicap is less relevant when working with native substrates 487 
such as sodium laureate and so this substrate was used as a model for studying the reusability 488 
of the self-sufficient biocatalyst. Firstly, the coupling efficiency of P450 towards this substrate 489 
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was determined and then reusability studies were performed using the self-sufficient 490 
P450/GDH biocatalysts obtained with the aforementioned carriers. 491 
Reactions using sodium laureate (1.3mM) and NADPH (0.2mM) were performed, monitoring 492 
and comparing substrates consumption by means of GC-FID. A coupling efficiency of 90.4% 493 
was observed, which means that, 90.4% of the NADPH consumed was employed for sodium 494 
laurate hydroxylation, with the remainder directed towards uncoupled reactions. This 495 
substrate was considered adequate to assess the operational stability of the enzymes in 496 
repeated reaction cycles.  497 
Total turnover number (mols of substrate consumed/mols of P450 BM3) (TTN) was chosen as 498 
the metric to evaluate the yield of the self-sufficient biocatalyst in comparison with the soluble 499 
lysate. To assess it, the immobilized P450 BM3/GDH (Epoxy-agarose-UAB, AMINO-agarose and 500 
Lentikats®) biocatalysts were tested in sodium laurate reaction cycles of 1 hour each utilizing 501 
glucose as the sacrificial substrate and the cofactor in its oxidized form (NADP+) thus forcing 502 
the cofactor regeneration to start before the P450-catalyzed reaction. Moreover, NADP+ 503 
starting concentration was 6.5-fold lower than the sodium laureate., The amount of P450 BM3 504 
required to convert > 90% of sodium laurate in 1 hour was found to be 0.18-0.2UA/mL (0.063-505 
0.07 nmols/mL). GDH on the other hand, was always ensured to be present in excess so that it 506 
did not limit the hydroxylation reaction. The conversions obtained in each cycle for the 507 
immobilized systems are presented in Figure 3. The TTN for the soluble reaction was 21,500 508 
mols of sodium laurate consumed/mol of P450 BM3 in 1 hour of reaction. The immobilized 509 
derivatives allowed the re-utilisation of the self-sufficient biocatalyst boosting the TTN by 2.31-510 
fold for the Epoxy-agarose-UAB, 2.98-fold for AMINO-agarose and 2.3-fold for the enzymes 511 
immobilized into Lentikats®. As shown in Figure 3, the conversion dropped in an exponential 512 
manner for epoxy-agarose (Figure 3A). On the contrary, with AMINO-agarose and Lentikats® 513 
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the decay was more linear (Figure 3B). At the end, all three derivates could be re-used 514 
successfully, thus demonstrating a significant operational stability. 515 
 516 
Conclusions 517 
P450 BM3 has gained much interest in recent years in biocatalysis for its oxy-functionalization 518 
characteristics, although, the implementation of this enzyme in industrial processes has lacked 519 
optimal metrics. Operational stability as well as its requirement of NADPH in stoichiometric 520 
amounts have been identified as the main bottlenecks. Aiming to overcome these two main 521 
drawbacks, P450 BM3 and GDH have been co-immobilized in the present work to obtain a 522 
robust bi-functional self-sufficient biocatalyst.  523 
P450 BM3 and GDH were covalently co-immobilized on epoxy-functionalized agarose and 524 
amino-functionalized agarose. Both enzymes were also successfully co-immobilized by 525 
entrapment in a polyvinyl alcohol/polyethylen-glycol matrix named Lentikats®. From the five 526 
epoxy-agaroses tested, the optimal support (Epoxy-agarose-UAB) presented an epoxide 527 
concentration of 30µmol/g and retained activities of 83% for P450 BM3 and 20% for GDH. On 528 
the other hand, AMINO-agarose showed retained activities of 28% for P450 and 25% for GDH. 529 
Finally, the entrapment of both enzymes in Lentikats ® lead to P450 BM3 and GDH co-530 
immobilization maintaining 100% of the activity initially loaded.  531 
P450 BM3 was also immobilized on aldehyde-functionalized agarose and presented 45% 532 
retained activity. However, this support did not allow high enzyme loads required for reaction 533 
testing, thus making this support unattractive for further studies.  534 
The operational stability of the obtained bi-functional self-sufficient biocatalysts (Epoxy-535 
agarose-UAB, AMINO-agarose and Lentikats®) was analysed in terms of re-usability for sodium 536 
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laureate oxidation.  All three derivatives showed successful reuse in 5 cycles, entailing an 537 
increment in the TTN of 2.31-fold the Epoxy-agarose-UAB, 2.98-fold the AMINO-agarose and 538 
2.3-fold the Lentikats® compared to the soluble enzymes.  539 
The P450 BM3 wild type served as a model in the immobilization studies in this work. On the 540 
other hand, mutated P450 BM3s, usually required for oxidative reactions of non-natural 541 
substrates which entail high uncoupling effects, can follow the exact same principles reported 542 
here since the surface of the enzyme is usually unaffected [1], [5], [6], [45]. In this sense, 543 
immobilization can be an added value to the process, for these new enzymes, due to the many 544 
advantages that it confers. 545 
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Table 1. Characterization of the cell free extract containing P450 BM3 and Glucose 697 
dehydrogenase. 698 
 699 
*Data obtained from SDS-PAGE analysis 700 
†Data obtained from CO difference spectrum assay 701 
 702 
 703 
 704 
 705 
 706 
 707 
 708 
 709 
 710 
 711 
Enzyme 
[Protein] (mg 
protein/mL 
lysate) 
Specific 
Activity 
(U/mg 
protein) 
Enzyme* (mg 
enz/mg prot) 
P450 BM3 active form 
concentration† (µM) 
P450 BM-3 
45.4 
2.82 0.524 44.9 
GDH 3.63 0.146 - 
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Table 2. Main characteristics of the matrices tested and their results regarding immobilization and retained activity of P450 BM3. The criterion chosen to 712 
select a support for further studies sets a minimum for Immobilization at 90% and 25% for Retained activity.  713 
Code 
Functional 
group 
(Linker) 
Matrix Interaction Pore diameter (Å) 
Particle 
size 
(µm) 
Immobilization 
Yield (%) 
Retained acitivty (%) 
ECR8204F Epoxy Methacrylate Covalent 300-600 150-300 92 0 
ECR8215F Epoxy Methacrylate Covalent 1200-1800 150-300 99 2 
ECR8309F 
Amino 
(C2) 
Methacrylate Ionic/Covalent 600-1200 150-300 95 3 
ECR8315F 
Amino 
(C2) 
Methacrylate Ionic/Covalent 1200-1800 150-300 97 4 
ECR8409F 
Amino 
(C6) 
Methacrylate Ionic/Covalent 600-1200 150-300 100 6 
ECR8415F 
Amino 
(C6) 
Methacrylate Ionic/Covalent 1200-1800 150-300 98 18 
ECR8285 Epoxy (C4) Methacrylate Ionic/Covalent 400-600 300-710 100 3 
ECR8806F 
None 
(C18) 
Methacrylate Hydrophobic 500-700 150-300 93 0 
ECR1061M None Styrene/Methacrylic Hydrophobic 600-750 300-710 21 0 
ECR1030M None Styrene/Methacrylic Hydrophobic 200-300 300-710 33 7 
Praesto 45 Epoxy Agarose Covalent ND 45 92 63 
Praesto 65 Epoxy Agarose Covalent ND 65 95 68 
Praesto 90 Epoxy Agarose Covalent ND 90 95 60 
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FIGURES 714 
 715 
Figure 1. P450 BM3 immobilization onto: A) Praesto 45 [discontinued line (-----)], 65 [dotted 716 
line (·····)] and 90 [combined dotted and discontinued line (-··-··-)] [Sodium Phosphate Buffer 717 
1M pH 8] B) Epoxy-agarose-Sigma [Sodium Phosphate Buffer 1M pH 8]; (I) the enzyme is 718 
bound to the support (II) β-mercaptoethanol 0.2M final concentration is added to eliminate 719 
the unreacted epoxy groups, C) Epoxy-agarose-UAB [Sodium Phosphate Buffer 1M pH 8] and 720 
D) AMINO-agarose [Sodium phosphate buffer 0,05M pH 6]; (I) adsorption of the enzyme to the 721 
support (II) incubation with certain amount of carbodiimide (EDC) (III) incubation with 0.5M 722 
NaCl and desorption of the unattached protein. The activity offered always ranged from 3.5 to 723 
6 UA/g of resin. The activities of a blank (squares), the supernatant (rhombus) and the 724 
suspension (triangle) were continuously analysed. Error bars correspond to standard deviation 725 
(n=2).  726 
 727 
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 728 
Figure 2. Optimization of the EDC concentration in AMINO-agarose experiments using high 729 
loads. The immobilization was carried out using sodium phosphate buffer 50mM pH 6 and 730 
offering 92UA/g of resin. Retained activity (black dots) and immobilization yield (grey bars) are 731 
represented. Error bars correspond to standard deviation (n=2). 732 
 733 
 734 
 735 
 736 
 737 
 738 
 739 
 740 
 741 
 742 
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Figure 3. Reaction cycles using both P450 BM3 and GDH immobilized onto: A) Epoxy-agarose-745 
UAB (10mg of agarose/mL), B) AMINO-agarose (10mg of agarose/mL) and C) Lentikats® (50mg 746 
of Lentikats/mL). Reactions were carried on in 5mL scale adding 0.18-0.2UA of total activity 747 
and using sodium phosphate buffer 50mM pH 7.5, 1.3mM sodium laurate, 0.2mM NADP+, 748 
12.5mM D-glucose, temperature control at 25°C and constant 1000rpm agitation using a 749 
Multi-Therm H5000-HC-E thermos shaker. Error bars correspond to standard deviation (n=2) 750 
